Literature DB >> 27788454

Tobacco use is associated with increased plasma BDNF levels in depressed patients.

Romain Colle1, Séverine Trabado2, Samuel Rotenberg1, Sylvie Brailly-Tabard2, Amine Benyamina3, Henri-Jean Aubin3, Patrick Hardy1, Bruno Falissard4, Laurent Becquemont5, Céline Verstuyft5, Bruno Fève6, Emmanuelle Corruble7.   

Abstract

Since serum Brain Derived Neurotrophic Factor (BDNF) levels are higher in tobacco smokers than in non-smokers and since Major Depressive Disorder (MDD) is associated with a 2-fold increased risk of smoking, we assessed the association of smoking and plasma BDNF levels in 359 depressed MDD patients. Plasma BDNF levels were positively correlated with the magnitude of tobacco consumption (current number of cigarettes/day and number of packs/year). Accordingly, current tobacco users had significantly higher plasma BDNF levels than non-users. In further studies of MDD, peripheral measures of BDNF should take into account tobacco use.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27788454     DOI: 10.1016/j.psychres.2016.10.012

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  6 in total

1.  Higher BDNF plasma levels are associated with a normalization of memory dysfunctions during an antidepressant treatment.

Authors:  Jan Engelmann; Stefanie Wagner; Daniel Wollschläger; Sabine Kaaden; Konrad F Schlicht; Nadine Dreimüller; Dieter F Braus; Marianne B Müller; Oliver Tüscher; Helge Frieling; André Tadić; Klaus Lieb
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-03-30       Impact factor: 5.270

2.  Increased BDNF methylation in saliva, but not blood, of patients with borderline personality disorder.

Authors:  Mara Thomas; Nora Knoblich; Annalena Wallisch; Katarzyna Glowacz; Julia Becker-Sadzio; Friederike Gundel; Christof Brückmann; Vanessa Nieratschker
Journal:  Clin Epigenetics       Date:  2018-08-22       Impact factor: 6.551

3.  Effects of smoking on cognition and BDNF levels in a male Chinese population: relationship with BDNF Val66Met polymorphism.

Authors:  Haisen Xia; Xiangdong Du; Guangzhong Yin; Yingyang Zhang; Xiaosi Li; Junyi Cai; Xingbing Huang; Yuping Ning; Jair C Soares; Fengchun Wu; Xiang Yang Zhang
Journal:  Sci Rep       Date:  2019-01-18       Impact factor: 4.379

4.  Gender Differences in Developing Biomarker-Based Major Depressive Disorder Diagnostics.

Authors:  Mike C Jentsch; Huibert Burger; Marjolein B M Meddens; Lian Beijers; Edwin R van den Heuvel; Marcus J M Meddens; Robert A Schoevers
Journal:  Int J Mol Sci       Date:  2020-04-25       Impact factor: 5.923

5.  The effect of smoking on cognition as measured by Cambridge Neuropsychological Test Automated Battery (CATNAB) and brain-derived neurotrophic factor plasma levels.

Authors:  Arwa Ali S Al-Mshari; Mona H AlSheikh; Rabia Latif; Sadaf Mumtaz
Journal:  Saudi Med J       Date:  2020-12       Impact factor: 1.484

6.  BDNF Plasma Levels and BDNF Exon IV Promoter Methylation as Predictors for Antidepressant Treatment Response.

Authors:  Klaus Lieb; Nadine Dreimüller; Stefanie Wagner; Konrad Schlicht; Tanja Falter; Alexandra Neyazi; Linda Müller-Engling; Stefan Bleich; André Tadić; Helge Frieling
Journal:  Front Psychiatry       Date:  2018-10-26       Impact factor: 4.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.